A director of Aveanna Healthcare Holdings Inc. sold 16.75 million shares of common stock for approximately $192.6 million in transactions concluded on August 20 and 21, 2026.
Robert M. Williams Jr., a director and 10% owner of Aveanna, disposed of the shares through several entities, including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and multiple JHW Iliad Holdings affiliates. The sales were executed at $11.50 per share, below the company’s current market price of $13.70.
Aveanna’s stock has gained 84% over the past year and is trading near its 52-week high of $13.98. The company reported Q2 2026 revenue of $670.5 million, exceeding forecasts by $31.9 million and rising 13.7% year-over-year. Analysts have adjusted price targets upward, with RBC Capital raising its target to $16.00 and Raymond James to $15.00, both maintaining buy ratings.
The transactions followed Aveanna’s announcement of a secondary offering of 15 million shares by certain selling shareholders, including affiliates of J.H. Whitney Equity Partners VII, LLC. Underwriters retained a 30-day option to purchase up to an additional 2.25 million shares from J.H. Whitney affiliates.
